Tuberculosis as a risk factor for systemic lupus erythematosus: Results of a nationwide study in Taiwan

Rheumatology International

Volumn 32, Issue 6, 2012, Pages 1669-1673

  Lin, Yu Chao ^a   Liang, Shinn Jye ^a   Liu, Yi Heng ^a   Hsu, Wu Huei ^a   Shih, Chuen Ming ^a   Sung, Fung Chang ^a,b   Chen, Wei ^b,c,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Health insurance; Risk factor; Systemic lupus erythematosus; Tuberculosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HUMAN; ICD-9-CM; INCIDENCE; INCOME; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; TUBERCULOSIS; URBAN AREA; WHITE COLLAR WORKER;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DATABASES, FACTUAL; ENDEMIC DISEASES; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TIME FACTORS; TUBERCULOSIS; YOUNG ADULT;

EID: 84863883710     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1847-5     Document Type: Article

References (26)

1. Bertsias GK, Salmon JE, Boumpas DT (2010) Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 69:1603-1611
2. Pavlovic M, Kats A, Cavallo M et al (2010) Clinical and molecular evidence for association of SLE with parvovirus B19. Lupus 19:783-792
3. Svensson E, Millet J, Lindqvist A et al (2010) Impact of immigration on tuberculosis epidemiology in a low burden country. Clin Microbiol Infect doi:10.1111/j.1469-0691.2010.03358.x
4. Furlow B (2010) Tuberculosis: a review and update. Radiol Technol 82:33-52
5. Hehenkamp A, Hargreaves S (2003) Tuberculosis treatment in complex emergencies: South Sudan. Lancet 362(Suppl):s30-s31
6. Frieden TR, Sterling TR, MunsiV SS et al (2003) Tuberculosis. Lancet 362:887-899
7. Corbett EL, Watt CJ, Walker N et al (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163:1009-1021
8. Holoshitz J, Matitiau A, Cohen IR (1984) Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 73:211-215
9. van Eden W, Holoshitz J, Nevo Z et al (1985) Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82:5117-5120
10. Shoenfeld Y, Schwartz RS (1984) Immunologic and genetic factors in autoimmune diseases. N Engl J Med 311:1019-1029
11. Sayarlioglu M, Inanc M, Kamali S et al (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 13:274-278
12. Yun JE, Lee SW, Kim TH et al (2002) The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127-132
13. Ghosh K, Patwardhan M, Pradhan V (2009) Mycobacterium tuberculosis infection precipitates SLE in patients from endemic areas. Rheumatol Int 29:1047-1050
14. Hsueh PR, Liu YC, So J et al (2006) Mycobacterium tuberculosis in Taiwan. J Infect 52:77-85
15. Naleway AL, Davis ME, Greenlee RT et al (2005) Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 14:862-866
16. Nightingale AL, Farmer RD, de Vries CS (2006) Incidence of clinically diagnosed systemic lupus erythematosus 1992-1998 using the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 15:656-661
17. Iseki K, Miyasato F, Oura T et al (1994) An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 23:547-554
18. Chiu YM, Lai CH (2010) Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus 19:1250-1255
19. Huang JL, Yao TC, See LC (2004) Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol 22:776-780
20. Wang TF, Lin HC (2008) Relationship between caseload volume and outcome for systemic lupus erythematosus treatment: the experience of Taiwan. J Rheumatol 35:1795-1800
21. Lindqvist KJ, Coleman RE, Osterland CK (1970) Autoantibodies in chronic pulmonary tuberculosis. J Chronic Dis 22:717-725
22. Singer JM, Plotz CM, Perlata FM et al (1962) The presence of anti-gamma globulin factors in sera of patients with active pulmonary tuberculosis. Ann Intern Med 56:545-552
23. Alarcon-Segovia D, Fishbein E (1975) Patterns of antinuclear antibodies and lupus-activating drugs. J Rheumatol 2:167-171
24. Sarzi-Puttini P, Atzeni F, Capsoni F et al (2005) Drug-induced lupus erythematosus. Autoimmunity 38:507-518
25. Shoenfeld Y, Vilner Y, Coates AR et al (1986) Monoclonal antituberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255-261
26. Correa PA, Gomez LM, Cadena J et al (2005) Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219-224